• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDSHAPE, INC. DYNACLIP 2-LEG STAPLE; STAPLE, FIXATION, BONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDSHAPE, INC. DYNACLIP 2-LEG STAPLE; STAPLE, FIXATION, BONE Back to Search Results
Catalog Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Implant Pain (4561)
Event Date 01/12/2024
Event Type  Injury  
Manufacturer Narrative
On (b)(6), customer notified medshape of 1 broken dynaclip 2-leg staple that required removal from the patient due to reported pain.The original surgery was completed on this patient on (b)(6) 2021 and the staple functioned successfully to fuse the impacted bones.All additional information for exact part number, size and lot number of the staple was unavailable at the time of the report.Remaining specifics of staple implant, case information, patient notes, operative notes, and information to determine conclusive cause is unknown at this time and multiple requests have been made to obtain information needed for investigation.The device failure, which resulted in patient pain and removal, fits the category requiring a 30-day mdr to report per qs-8.2.1.3, sop, medical device reporting.In response to this event, qsf-8.2.1.2, health risk assessment form has been completed.Based on review of images of broken staples, a potential failure mode and root cause have been identified.Given the potential root cause (still to be confirmed pending receipt of additional information), health risk and failure mode analysis in qsf-8.2.1.2 have identified that the likelihood of this same manner of staple breakage occurring in the field is extremely unlikely, coupled with an extremely high success rate of these staples, no field action or market removal is necessary for this complaint.A supplemental mdr report will be filed for complaint 24-01-008 when all necessary information has been obtained and the complaint investigation has been completed.
 
Event Description
On (b)(6), customer notified medshape of 1 broken dynaclip 2-leg staple that required removal from the patient due to reported pain.The original surgery was completed on this patient in (b)(6) 2021 and the staple functioned successfully to fuse the impacted bones.All additional information for exact part number, size and lot number of the staple was unavailable at the time of the report.
 
Manufacturer Narrative
In conclusion, this investigation determined that the root cause of the staple breakage was that the rev.01 design of ed-10697.[tab] 2 leg dynaclip staple and rev.01 design of ed-10869.[tab] did not optimize even distribution of strain across the legs during high stress loading conditions.Review of the imaging provided shows that the breakage in this staple occurred in the general region with the highest for potential strain on the leg as was determined in cro-2021-0081 fea maximum loading condition analysis.While no injuries, incidents or pain was reported between the time of original implantation to the time of the reported of staple breakage, it can be concluded the 1 or more events may have occurred in the patient post-operatively that were similar to the maximum loading conditions in fea analysis, as the breakage was in the location of highest potential strain concentration.Following manufacturing of the complaint staple unit, the design of both the 2-leg staple (ed-10697) and the 4 leg inline staple (ed-10869) were revised from rev.01 to rev.02 under cro-2021-0081.As this event had reported patient pain, requiring removal of the broken staple, a 30-day mdr report was filed to fda as per qs-8.2.1.7, sop, medical device reporting.Qsf-8.2.1.2, health risk assessment form was completed and approved for this complaint, which determined that no market recall / removal was necessary.The occurrence rate of staples breaking with a cause attributable to the old revision design is approximately (b)(4).Despite the staple breakage and removal, both staples functioned properly to facilitate full bone fusion.As the design change to improve the strain profile of dynaclip 2-leg and 4-leg staples has been completed in may 2021, no further corrective actions are necessary at this time for the reasons listed above and based on completed health risk assessment form qsf-8.2.1.2.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DYNACLIP 2-LEG STAPLE
Type of Device
STAPLE, FIXATION, BONE
Manufacturer (Section D)
MEDSHAPE, INC.
1575 northside dr nw
suite 440
atlanta GA 30318
Manufacturer (Section G)
MEDSHAPE, INC.
1575 northside dr nw
suite 440
atlanta GA 30318
Manufacturer Contact
justin lovelace
1575 northside dr nw
suite 440
atlanta, GA 30318
4805161552
MDR Report Key18682059
MDR Text Key335073674
Report Number3007593722-2024-00001
Device Sequence Number1
Product Code JDR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K181781
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 03/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/09/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received02/20/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age45 YR
Patient SexMale
-
-